SPY
751.30
QQQ
682.34
+0.18%
BTC/USD
76,908.23
+0.31%
DIA
516.86
−0.48%
GLD
357.82
−1.06%
TLT
81.67
−0.07%
Try
Free
US
Sign in
Register
My Account
Benzinga
Premium Services
Services
Markets & News
Markets
Stocks & Sectors
Stocks
Ratings & Research
Ratings
Trading
Trading
Screeners & Lists
Screeners
Learn
Learn
Premium Services
Markets & News
Breaking headlines, the trading day, and the calendars that move it.
Stocks & Sectors
Research any ticker, then drill into sectors, ratings, and options.
Ratings & Research
Wall Street calls, insider moves, and Benzinga's own stock rankings.
Trading
Options flow, trade calculators, and ideas for active traders.
Screeners & Lists
Filter the market your way, or start from a curated list.
Learn
Pick a broker, grow your savings, and protect what you've built.
Premium Services
Edge
Ratings, signals & screens
Pro
Real-time news & data terminal
Research
Trade alerts & newsletters
APIs
Market data licensing
All sections
Biote Corp
BTMD
NASDAQ
Watchlist
Get Report
Trade with Public
Get Report
Trade with Public
$1.13
0.02
1.8%
Last update: Nov 2, 7:33 AM
Get Report
Overview
News
Earnings Forecast
Price Targets
Financials
Sentiment
Ownership
Compare
Stock Report
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga
Edge
Benzinga
Research
Benzinga
Pro
Logout
Earnings:
Q3 2026 earnings tomorrow on Wed Nov 4th after the market close
Conference Call:
Conference call scheduled tomorrow at 5:00 PM
Click to view the webcast
Biote Financials
Biote (BTMD) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
Biote FY2026 Revenue expected to be more than $175.000M vs $190.807M Est
Biote (NASDAQ:BTMD) FY2026 Revenue expected to be more than $175.000M vs $190.807M Est
Benzinga Newsdesk
PRO
Biote Q2 EPS $(0.23) Misses $0.04 Estimate, Sales $44.232M Miss $46.148M Estimate
Biote (NASDAQ:BTMD) reported quarterly losses of $(0.23) per share which missed the analyst consensus estimate of $0.04 by 675 percent. This is a 330 percent decrease over earnings of $0.10 per share from the same
Benzinga Newsdesk
PRO
Biote Reaffirms FY26 Guidance For Revenue Above $190M And Adjusted EBITDA Above $38M
Biote reaffirmed its full year 2026 guidance for revenue above $190 million, Adjusted EBITDA above $38 million, and a return to procedure revenue growth in the second half of this year.
Benzinga Newsdesk
Earnings Scheduled For May 6, 2026
Benzinga Insights
PRO
Biote Q1 EPS $0.06 Beats $0.03 Estimate, Sales $44.935M Miss $46.023M Estimate
Biote (NASDAQ:BTMD) reported quarterly earnings of $0.06 per share which beat the analyst consensus estimate of $0.03 by 100 percent. This is a 83.78 percent decrease over earnings of $0.37 per share from the same period
Benzinga Newsdesk
PRO
Biote Sees FY2026 Sales $190.000M vs $196.193M Est
Biote (NASDAQ:BTMD) sees FY2026 sales of $190.000 million vs $196.193 million analyst estimate.
Benzinga Newsdesk